ARS Pharmaceuticals, Inc.
Total Trades
89
Buys
7
Sells
57
Largest Trade
$1M+
Insiders
13
Institutional Funds
147
Inst. Value
$1M+
Activist Filings
27
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dorsey Brian | COO | EXERCISE | $1K–$15K | 22K | $0.64 | Nov 14, 2025 |
| Dorsey Brian | COO | SELL | $100K–$500K | 22K | $8.71 | Nov 14, 2025 |
| Chakma Justin | Chief Business Off… | SELL | $1M+ | 166K | $8.87 | Nov 14, 2025 |
| Chakma Justin | Chief Business Off… | EXERCISE | $15K–$50K | 30K | $0.84 | Nov 14, 2025 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $500K+ | 50K | $14.49 | Aug 22, 2025 |
| Scott Kathleen D. | CFO | SELL | $100K–$500K | 13K | $15.00 | Aug 22, 2025 |
| Scott Kathleen D. | CFO | EXERCISE | $15K–$50K | 13K | $1.50 | Aug 22, 2025 |
| Karas Eric | Chief Commercial O… | EXERCISE | $15K–$50K | 15K | $1.50 | Jul 3, 2025 |
| Karas Eric | Chief Commercial O… | SELL | $100K–$500K | 15K | $16.99 | Jul 3, 2025 |
| Flynn James E | 10% Owner | SELL | $1M+ | 740K | $18.46 | Jul 1, 2025 |
| Karas Eric | Chief Commercial O… | SELL | $100K–$500K | 15K | $16.00 | Jun 20, 2025 |
| Karas Eric | Chief Commercial O… | EXERCISE | $15K–$50K | 15K | $1.50 | Jun 20, 2025 |
| Fitzpatrick Alexander A | Chief Legal Officer | EXERCISE | $500K+ | 100K | $5.58 | May 22, 2025 |
| Fitzpatrick Alexander A | Chief Legal Officer | SELL | $1M+ | 103K | $14.10 | May 22, 2025 |
| SAUNDERS BRENT L | Director | SELL | $1M+ | 120K | $14.25 | May 22, 2025 |
| SAUNDERS BRENT L | Director | EXERCISE | $100K–$500K | 120K | $1.01 | May 22, 2025 |
| Scott Kathleen D. | CFO | SELL | $500K+ | 50K | $14.10 | May 22, 2025 |
| Scott Kathleen D. | CFO | EXERCISE | $50K–$100K | 50K | $1.50 | May 22, 2025 |
| Shawver Laura | Director | SELL | $500K+ | 50K | $12.30 | Apr 8, 2025 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 50K | $4.85 | Apr 8, 2025 |
| Karas Eric | Chief Commercial O… | SELL | $100K–$500K | 10K | $14.00 | Mar 21, 2025 |
| Karas Eric | Chief Commercial O… | EXERCISE | $15K–$50K | 10K | $1.50 | Mar 21, 2025 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 50K | $3.15 | Jan 7, 2025 |
| Shawver Laura | Director | SELL | $500K+ | 50K | $11.10 | Jan 7, 2025 |
| Chakma Justin | Chief Business Off… | SELL | $1M+ | 90K | $13.43 | Dec 5, 2024 |
| Chakma Justin | Chief Business Off… | EXERCISE | $50K–$100K | 90K | $0.84 | Dec 5, 2024 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 200K | $2.00 | Dec 5, 2024 |
| Shawver Laura | Director | SELL | $1M+ | 200K | $13.44 | Dec 5, 2024 |
| Karas Eric | Chief Commercial O… | SELL | $100K–$500K | 10K | $14.04 | Dec 5, 2024 |
| Karas Eric | Chief Commercial O… | EXERCISE | $15K–$50K | 10K | $1.50 | Dec 5, 2024 |
| Chakma Justin | Chief Business Off… | SELL | $1M+ | 100K | $14.12 | Nov 27, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $1M+ | 100K | $13.95 | Nov 21, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $1M+ | 100K | $13.95 | Nov 21, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $1M+ | 100K | $16.85 | Nov 14, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $1M+ | 100K | $16.85 | Nov 14, 2024 |
| Flynn James E | 10% Owner | SELL | $1M+ | 563K | $18.01 | Nov 14, 2024 |
| Scott Kathleen D. | CFO | SELL | $100K–$500K | 13K | $16.00 | Oct 17, 2024 |
| Scott Kathleen D. | CFO | EXERCISE | $15K–$50K | 13K | $1.50 | Oct 17, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $1M+ | 100K | $14.88 | Oct 17, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $1M+ | 100K | $14.88 | Oct 17, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $1M+ | 100K | $13.83 | Oct 10, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $1M+ | 100K | $13.83 | Oct 10, 2024 |
| Thompson Peter A. | Director | SELL | $1M+ | 84K | $13.00 | Aug 28, 2024 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 84K | $13.00 | Aug 28, 2024 |
| Thompson Peter A. | Director | SELL | $1M+ | 869K | $13.24 | Aug 23, 2024 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 869K | $13.24 | Aug 23, 2024 |
| Dorsey Brian | COO | SELL | $500K+ | 50K | $15.00 | Aug 21, 2024 |
| Dorsey Brian | COO | EXERCISE | $15K–$50K | 50K | $0.64 | Aug 21, 2024 |
| Karas Eric | Chief Commercial O… | EXERCISE | $15K–$50K | 10K | $1.50 | Aug 21, 2024 |
| Karas Eric | Chief Commercial O… | SELL | $100K–$500K | 10K | $14.00 | Aug 21, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 147 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.9M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 8.3M | $1M+ | SH |
| Rubric Capital Management LP | 6.2M | $1M+ | SH |
| SR ONE CAPITAL MANAGEMENT, LP | 4.0M | $1M+ | SH |
| Aberdeen Group plc | 3.6M | $1M+ | SH |
| STATE STREET CORP | 3.2M | $1M+ | SH |
| Tyro Capital Management LLC | 2.0M | $1M+ | SH |
| Tyro Capital Management LLC | 2.0M | $1M+ | SH |
| Southpoint Capital Advisors LP | 1.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $1M+ | SH |
| Janney Montgomery Scott LLC | 1.3M | $1M+ | SH |
| LEVIN CAPITAL STRATEGIES, L.P. | 748K | $1M+ | SH |
| Nextech Invest, Ltd. | 661K | $1M+ | SH |
| BANK OF MONTREAL /CAN/ | 643K | $1M+ | SH |
| CenterBook Partners LP | 568K | $1M+ | SH |
| GENERAL AMERICAN INVESTORS CO INC | 560K | $1M+ | SH |
| Third Point LLC | 556K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 456K | $1M+ | SH |
| Alyeska Investment Group, L.P. | 419K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 13, 2026
6.3%
6.2M shares
SC 13G · Jan 21, 2026
5.1%
5.0M shares
SC 13D/A · Oct 2, 2025
11.1%
10.9M shares
SC 13D/A · Aug 1, 2025
3.9%
3.8M shares
SC 13D/A · Jul 22, 2025
4.4%
4.3M shares
SC 13D/A · Jul 2, 2025
5.0%
4.9M shares
SC 13D/A · Mar 24, 2025
5.4%
5.3M shares
The Pratik Shah Living Trust dated June 15, 2011(1) 2.
SC 13D/A · Jun 18, 2024
5.4%
5.2M shares
The Pratik Shah Living Trust dated June 15, 2011(1) 2.
SC 13D/A · Jun 11, 2024
6.8%
6.6M shares
SC 13D/A · Mar 29, 2024
11.3%
10.9M shares
SC 13D/A · Sep 25, 2023
9.9%
9.5M shares
SC 13D/A · Sep 1, 2023
4.5%
4.3M shares
SC 13D · Aug 31, 2023
7.1%
6.8M shares
SC 13G/A · Feb 14, 2023
2.0%
1.9M shares
SC 13G/A · Feb 13, 2023
2.2%
2.0M shares
SC 13D/A · Nov 30, 2022
8.3%
7.8M shares
SC 13D · Nov 21, 2022
9.1%
8.6M shares
SC 13D · Nov 18, 2022
5.9%
5.5M shares
The Pratik Shah Living Trust dated June 15, 2011(1)
SC 13D · Nov 18, 2022
10.8%
10.2M shares
Richard E. Lowenthal, M.S., MSEL
SC 13D · Nov 18, 2022
7.9%
7.4M shares
SC 13D · Nov 18, 2022
6.7%
6.3M shares
SC 13G · Jul 15, 2022
5.4%
1.9M shares
SC 13G/A · Feb 14, 2022
0 shares
SC 13G/A · Feb 14, 2022
5.0%
1.7M shares
SC 13G/A · Feb 14, 2022
3.0%
1.1M shares
Wasatch Advisors, Inc. 87-0319391
SC 13G · Feb 10, 2022
5.1%
1.8M shares
U.S. Venture Partners XII, L.P. (“USVP XII”)
SC 13D · Jan 27, 2022
0.0%
0 shares